©2022 Stanford Medicine
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
Recruiting
I'm InterestedTrial ID: NCT05343793
Purpose
The purpose of this study is to expand access to medications for opioid use disorder (MOUD)
in specialty addiction programs in Washington State. Sixty-four addiction treatment programs
will participate in an adaptive implementation strategy trial that uses a stagewise
implementation-to-target (stepped "care" type) approach whereby organizations engage in
increasingly intensive implementation strategies as needed. Organizations are moved to a
follow-up/sustainment arm once they have met the implementation targets described below. The
design also includes an external comparator arm, which consists of 510 addiction treatment
programs that are not participating in the study and will mimic as study controls.
The sequence of implementation strategies are:
1. Enhanced Monitoring and Feedback
2. NIATx/MAT Academy
3. Randomization to either NIATx Internal Facilitation or NIATx External Facilitation
4. Assignment to NIATx External Facilitation if outcome targets are not achieved in the
NIATx Internal Facilitation arm
Implementation targets are:
1. Reach - At least 75% of patients with opioid use disorder (OUD) receiving MOUD for three
consecutive months
2. Adoption - At least 1 integrated MOUD prescriber actively prescribing MOUD
3. Implementation - a total score ≥ 4 on the Integrating Medications for Addiction
Treatment (IMAT) Index.
Contextual moderators and mediators of performance on target outcomes as a function of the
implementation strategy step will be examined, as will the costs associated with
participation in the sequence of implementation strategies.
Official Title
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
- Addiction treatment programs in Washington State
- Residential (detoxification or rehabilitation) or outpatient (intensive outpatient or
outpatient) levels of care
- Primary care clinics, including Federally Qualified Health Centers (FQHCs) and
Community Health Centers (CHCs)
Exclusion Criteria:
- Opioid treatment programs
Intervention(s):
other: Enhanced Monitoring and Feedback (EMF)
other: NIATx/MAT Academy
other: NIATx-Internal Facilitation (NIATx-IF)
other: NIATx-External Facilitation (NIATx-EF)
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Helene Chokron Garneau, PhD, MPH
650-721-1317